Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingPhase 12026-09-11NCT04972942

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
New York Medical College28

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Boston Children's HospitalBostonUnited States343
Children's Hospital ColordaoAuroraUnited States1
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Children's National Medical CenterWashington D.C.United States177
Helen DeVos Children's HospitalGrand RapidsUnited States23
John Hopkins All Children's HospitalSt. PetersburgUnited States1
Loma Linda University Children's HospitalLoma LindaUnited States7
MD Anderson Cancer CenterHoustonUnited States589
Medical College of WisconsinMilwaukeeUnited States483
Nationwide Children's HosptialColumbusUnited States9
New York Medical CollegeVallhalaUnited States4
Phoenix Children's HospitalPhoenizUnited States1
Riley Children's HospitalIndianapolisUnited States17
University of CaliforniaLos AngelesUnited States11
University of CaliforniaSan FranciscoUnited States14
University of FloridaGainsvilleUnited States1